Source: Eur Respir Rev 2016; 25: 418-430
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Harrison W. Farber, Wendy Gin-Sing. Practical considerations for therapies targeting the prostacyclin pathway. Eur Respir Rev 2016; 25: 418-430

Member's Comments

No comment yet.

Related content which might interest you: Clinical implications and novel therapies Source: International Congress 2018 – Accelerated ageing in lungs Year: 2018 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Targeting the arginase pathway: potential developments as new avenues for treatment Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma? Year: 2004 Achievements in targeted therapies Source: Eur Respir Monogr 2015; 68: 215-233 Year: 2015 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 How to disrupt malicious LC-fILD pathways: antifibrotic agents as a promising therapeutic approach Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists Year: 2021 Potential of regulatory T-cell-based therapies in the management of severe COVID-19 Source: Eur Respir J, 56 (3) 2002182; 10.1183/13993003.02182-2020 Year: 2020 Therapeutic implications Source: Annual Congress 2009 - The lung cancer-COPD nexus Year: 2009 Identification of mechanism-specific biomarkers to guide development of the lung-selective inhaled pan-JAK inhibitor TD-8236 Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 Challenges and limitations of individualised therapy Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Therapeutic management - Current status and future developments Source: COVID-19 Videos Year: 2020 Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19 Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020 Year: 2020 Targeting intermittent hypoxia downstream pathways for biomarker discovery and new treatment perspectives in cutaneous melanoma Source: Eur Respir J, 53 (2) 1802444; 10.1183/13993003.02444-2018 Year: 2019